Helicobacter pylori infection and chronic immune thrombocytopenic purpura: Long-term results of bacterium eradication and association with bacterium virulence profiles

Blood

Volumn 110, Issue 12, 2007, Pages 3833-3841

  Emilia, Giovanni ^a,b   Luppi, Mario ^a   Zucchini, Patrizia ^a   Morselli, Monica ^a   Potenza, Leonardo ^a   Forghieri, Fabio ^a   Volzone, Francesco ^a   Jovic, Gordana ^a   Leonardi, Giovanna ^a   Donelli, Amedea ^a   Torelli, Giuseppe ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACTERIAL PROTEIN; CAGA PROTEIN; CLARITHROMYCIN; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BAB A2; PROTEIN ICE A1; PROTEIN ICE A2; PROTEIN VACA M1; PROTEIN VACA M2; PROTEIN VACA S1; PROTEIN VACA S2; PROTON PUMP INHIBITOR; T CELL RECEPTOR GAMMA; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; GASTRITIS; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LONG TERM CARE; LYMPHOCYTE CLONE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; T LYMPHOCYTE; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

EID: 37049004014     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-12-063222     Document Type: Article

References (57)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347:1175-1186.
2. Gasbarrini A, Franceschi F. Autoimmune diseases and Helicobacter pylori infection. Biom Pharmacother. 1999;53:223-226.
3. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878.
4. Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood. 2001;97:812-814.
5. Emilia G, Luppi M, Morselli M, Potenza L, D'Apollo N, Torelli G. Helicobacter pylori infection and idiopathic thrombocytopenic purpura. Br J Haematol. 2002;118:1198-1199.
6. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol. 2002;118:584-588.
7. Veneri D, Franchini M, Gottardi M, et al. Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica. 2002;87:1177-1179.
8. Hino M, Yamane T, Park K, et al. Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol. 2003;82:30-32.
9. Ando K, Shimamoto T, Tauchi T, et al. Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review. Int J Hematol. 2003;77:239-244.
10. Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura. Am J Med. 2005;118:414-419.
11. Inaba T, Mizuno M, Take S, et al. Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan. Eur J Clin Invest. 2005;35:214-219.
12. Fujimura K, Kuwana M, Kurata Y, et al. Is eradication therapy useful as first line treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan. Int J Hematol. 2005;81:162-168.
13. Suzuki T, Matsushima M, Masui A, et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura: a randomized controlled trial. Am J Gastroenterol. 2005;100:1265-1270.
14. Veneri D, Krampera M, Franchini M. High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: a long-term follow-up study. Platelets. 2005;16:117-119.
15. Suvajdzic N, Stankovic B, Artiko V, et al. Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura. Platelets. 2006;17:227-230.
16. Sayan O, Akyol E, Ozturk A. The efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura: the first study in Turkey. Acta Haematol. 2006;116:146-149.
17. Campuzano-Maya G. Proof of an association between Helicobacter pylori and idiopathic thrombocytopenic purpura in Latin America. Helicobacter. 2007;12:265-273.
18. Emilia G, Luppi M, Torelli G. Infectious agents and human immune diseases: lessons from Helicobacter pylori. Am J Med. 2005;118:420-421.
19. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood. 1996;88:3-40.
20. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun. 1993;61:1799-1809.
21. Atherton JC, Cao P, Peck RM Jr, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995;270:17771-17777.
22. Rudi J, Rudy A, Maiwald M, et al. Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol. 1999;94:1525-1531.
23. van Doorn LJ, Figueiredo C, Sanna R, et al. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998;115:58-66.
24. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A. 1999;96:12778-12783.
25. Rudi J, Kolb C, Maiwald M, et al. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J Clin Microbiol. 1998;36:944-948.
26. De Re V, De Vita S, Carbone A, et al. The relevance of VDJ PCR protocols in detecting B-cell clonal expansion in lymphoma and other lymphoproliferative disorders. Tumori. 1995;81:405-409.
27. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by polymerase chain reaction. Blood. 1991;78:192-196.
28. Nam S-H, Kim B-S, Lee JH, et al. The clinical efficacy of Helicobacter pylori eradication in patients with Helicobacter pylori-positive chronic thrombocytopenic purpura [abstract]. Blood. 2005;106: 80b. Abstract no. 4002.
29. Jang JH, Kim HI, Lee HW, et al. Correlation between Helicobacter pylori eradication and platelet count in immune thrombocytopenic purpura (ITP) [abstract]. Blood. 2005;106:80b. Abstract no. 4003.
30. Jaing TH, Yang CP, Hung IJ, Chin CH, Chang KW. Efficacy of Helicobacter pylori eradication on platelet recovery in children with chronic idiopathic thrombocytopenic purpura. Acta Paediatr. 2003;92:1153-1157.
31. Neefjes VME, Heijboer H, Tamminga RYJ. H. pylori infection in childhood chronic immune thrombocytopenic purpura. Haematologica. 2007;92:576.
32. Michel M, Cooper N, Jean C, Frissora C, Bussel JB. Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood. 2004;103:890-896.
33. Ahn ER, Tiede MP, Jy W, Bidot CJ, Fontana V, Ahn YS. Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: eradication reduces platelet activation but seldom improves platelet counts. Acta Haematol. 2006;116:19-24.
34. Jarque I, Andreu R, Llopis I, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2001;115:1002-1003.
35. Garcia-Perez A, Valverde de la Osa J, Gimenez Samper M, Alonso Garcia I. Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori. Sangre (Barcelona). 1999;44:387-388.
36. Dominici P, Bellentani S, Di Biase AR, et al. Familial clustering of Helicobacter pylori infection: population based study. BMJ. 1999;319:537-540.
37. Russo A, Eboli M, Pizzetti P, et al. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur J Gastroenterol Hepatol. 1999;11:867-873.
38. Franchini M, Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter. 2004;9:342-346.
39. Michel M, Khellfar M, Desforges L, et al. Autoimmune thrombocytopenic purpura and Helicobacter pylori infection. Arch Intern Med. 2002;162:1033-1036.
40. Ando T, Tsuzuki T, Mizuno T, et al. Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura. Helicobacter. 2004;9:443-452.
41. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2004;124:91-96.
42. Arnold DM, Dentali F, Crowther MA, et al. Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Ann Intern Med. 2007;146:25-33.
43. Ohguchi H, Kameoka J, Harigae H, et al. Can the Helicobacter pylori eradication regimen induce platelet recovery in H. pylori-negative patients with idiopathic thrombocytopenic purpura? Am J Hematol. 2005;78:164-165.
44. Kuwana M, Okazaki Y, Kaburaki J, Kawakami Y, Ikeda Y. Spleen is a primary site for activation of platelet-reactive T and B cells in patients with immune thrombocytopenic purpura. J Immunol. 2002;168:3675-3682.
45. Olsson B, Andersson PO, Jernas M, et al. T-cellmediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-1124.
46. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2004;103:1364-1369.
47. Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut. 1998;43:52-55.
48. Veneri D, Gottardi M, Guizzardi E, Zanuso C, Krampera M, Franchini D. Idiopathic thrombocytopenic purpura, Helicobacter pylori infection, and HLA class II alleles. Blood. 2002;100:1925-1926.
49. Takahashi T, Yujiri T, Tanizawa T. Helicobacter pylori and chronic ITP: the discrepancy in the clinical responses to eradication therapy might be due to differences in the bacterial strains. Blood. 2004;104:594.
50. Byrne MF, Kerrigan SW, Corcoran PA, et al. Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology. 2003;124:1846-1854.
51. Kraft M, Tiemann M, Riedel S, et al. Compartment analysis of T cell receptor gamma-and immunoglobulin V (H) rearrangements by microdissection in patients with malt lymphoma and chronic gastritis with lymphatic hyperplasia. Cell Mol Biol (Noisy-le-grand). 2002;48:253-263.
52. Georgopoulos SD, Triantafyllou K, Fameli M, et al. Molecular analysis of B-cell clonality in Helicobacter pylori gastritis. Digest Dis Sci. 2005;50:1616-1620.
53. Veneri D, De Matteis G, Solero P, et al. Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: correlation with Helicobacter pylori infection and response to eradication treatment. Platelets. 2005;16:307-311.
54. Ishiyama M, Teramura M, Iwabe K, Kato T, Motoji T. Clonally expanded T-cells in the peripheral blood of patients with idiopathic thrombocytopenic purpura and Helicobacter pylori infection. Int J Haematol. 2006;83:147-151.
55. Kim J, Park CJ, Chi HS, et al. Idiopathic thrombocytopenic purpura: better therapeutic responses of patients with B- or T-cell clonality than patients without clonality. Int J Haematol. 2003;78:461-466.
56. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and S1 vacA genes work synergistically in causing intestinal metaplasia. J Clin Pathol. 2003;56:287-291.
57. Yamaoka Y, Kodama T, Gutierrez O, et al. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999;37:2274-2279.